Céline Rodriguez

972 total citations
14 papers, 489 citations indexed

About

Céline Rodriguez is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Céline Rodriguez has authored 14 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Céline Rodriguez's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Céline Rodriguez is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Céline Rodriguez collaborates with scholars based in France and Germany. Céline Rodriguez's co-authors include Christophe Caux, Margaux Hubert, Nathalie Bendriss‐Vermare, Christine Ménétrier‐Caux, Jenny Valladeau‐Guilemond, Karim Chikh, Gilles Millat, Marie T. Vanier, Vincent C. Lombardi and Laurie Besson and has published in prestigious journals such as Nature Communications, Blood and British Journal of Cancer.

In The Last Decade

Céline Rodriguez

13 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Céline Rodriguez France	8	220	195	134	77	68	14	489
Maxim Kebenko Germany	12	165 0.8×	265 1.4×	243 1.8×	43 0.6×	135 2.0×	30	609
Sabrina Bossio Italy	11	292 1.3×	251 1.3×	207 1.5×	74 1.0×	56 0.8×	30	601
Eric H. Bent United States	6	196 0.9×	165 0.8×	252 1.9×	45 0.6×	20 0.3×	10	525
Gina M. Ney United States	12	102 0.5×	82 0.4×	273 2.0×	82 1.1×	58 0.9×	19	438
Dazhong Zhuang United States	9	145 0.7×	135 0.7×	427 3.2×	138 1.8×	54 0.8×	12	639
Dalia Gilat Israel	10	181 0.8×	85 0.4×	170 1.3×	58 0.8×	62 0.9×	14	510
Andy Hsu Australia	6	104 0.5×	113 0.6×	200 1.5×	39 0.5×	106 1.6×	10	401
Paola Pittoni Italy	12	571 2.6×	170 0.9×	125 0.9×	37 0.5×	28 0.4×	13	689
Lilach Gutter-Kapon Israel	6	109 0.5×	139 0.7×	305 2.3×	54 0.7×	29 0.4×	6	477
Jonathan Keller United States	6	328 1.5×	94 0.5×	239 1.8×	29 0.4×	163 2.4×	8	608

Countries citing papers authored by Céline Rodriguez

Since Specialization

Citations

This map shows the geographic impact of Céline Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Rodriguez more than expected).

Fields of papers citing papers by Céline Rodriguez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Rodriguez. The network helps show where Céline Rodriguez may publish in the future.

Co-authorship network of co-authors of Céline Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Rodriguez. A scholar is included among the top collaborators of Céline Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Rodriguez. Céline Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rodriguez, Céline, Maude Ardin, Anne‐Claire Doffin, et al.. (2025). Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2. Nature Communications. 16(1). 3045–3045. 5 indexed citations

Tonon, Laurie, Dominique Poujol, Émilie Picard, et al.. (2025). Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features. Nature Communications. 16(1). 6135–6135.

Gomez‐Roca, Carlos, Sylvie Chabaud, Céline Rodriguez, et al.. (2024). The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers. Science Translational Medicine. 16(731). eadd1834–eadd1834. 32 indexed citations

Dalle, Stéphane, Estelle Verronèse, Céline Rodriguez, et al.. (2024). Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients. OncoImmunology. 13(1). 2372118–2372118. 1 indexed citations

Rodriguez, Céline, Emeline Cros‐Perrial, Christophe Mathé, et al.. (2023). Second‐Generation CD73 Inhibitors Based on a 4,6‐Biaryl‐2‐thiopyridine Scaffold. ChemMedChem. 18(7). e202200594–e202200594. 9 indexed citations

Hubert, Margaux, Laurie Besson, Céline Rodriguez, et al.. (2021). Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?. Cancers. 13(8). 1850–1850. 78 indexed citations

Hubert, Margaux, Élisa Gobbini, Coline Couillault, et al.. (2020). IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Science Immunology. 5(46). 105 indexed citations

Hubert, Margaux, Coline Couillault, Thien‐Phong Vu Manh, et al.. (2020). Abstract A70: IFN-III is selectively produced by cDC1 and predicts good clinical outcome in human breast cancer. Cancer Immunology Research. 8(4_Supplement). A70–A70. 1 indexed citations

Rodriguez, Céline, Margaux Hubert, Christelle Machon, et al.. (2019). Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production. Journal of Clinical Medicine. 8(11). 1859–1859. 5 indexed citations

10.

Renaud, Loïc, Olivier Nibourel, Céline Berthon, et al.. (2016). De Novo and Secondary Acute Myeloid Leukemia, Real World Data on Outcomes from the French Nord-Pas-De-Calais Picardie Acute Myeloid Leukemia Observatory. Blood. 128(22). 4013–4013. 4 indexed citations

11.

Dezutter‐Dambuyant, Colette, Isabelle Durand, Laurent Alberti, et al.. (2015). A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage. OncoImmunology. 5(3). e1091146–e1091146. 74 indexed citations

12.

Bibault, Jean‐Emmanuel, Martin Figeac, Nathalie Hélevaut, et al.. (2015). Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia. Oncotarget. 6(26). 22812–22821. 43 indexed citations

13.

Orsetti, Béatrice, Nathalie Cervera, Laurence Lasorsa, et al.. (2006). Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. British Journal of Cancer. 95(10). 1439–1447. 66 indexed citations

14.

Millat, Gilles, et al.. (2005). Niemann–Pick C disease: Use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families☆. Molecular Genetics and Metabolism. 86(1-2). 220–232. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact